Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
Iscience|November 22, 2021
Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2Junpei Ohtsuka, Masaki Imai, Masayuki Fukumura, et al.Scientific Reports|March 21, 2018
Experimental infection of Cynomolgus Macaques with highly pathogenic H5N1 influenza virus through the aerosol routeTokiko Watanabe, Kiyoko Iwatsuki-Horimoto, Maki Kiso, et al.JAMA|April 5, 2007
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsShuji Hatakeyama, Norio Sugaya, Mutsumi Ito, et al.One Health (Amsterdam, Netherlands)|June 26, 2023
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in JapanSeiya Yamayoshi, Mutsumi Ito, Kiyoko Iwatsuki-Horimoto, et al.The Journal of General Virology|July 2, 2010
Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern VietnamQuynh Mai Le, Mutsumi Ito, Yukiko Muramoto, et al.Ebiomedicine|June 7, 2025
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variantRyuta Uraki, Maki Kiso, Mutsumi Ito, et al.Emerging Microbes & Infections|January 9, 2025
Highly pathogenic avian H5N1 influenza A virus replication in ex vivo cultures of bovine mammary gland and teat tissuesMasaki Imai, Hiroshi Ueki, Mutsumi Ito, et al.Internal Medicine (Tokyo, Japan)|January 3, 2024
Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological MalignanciesMasao Hagihara, Hiroyoshi Hayashi, Shiori Nakashima, et al.Frontiers in Microbiology|July 11, 2018
Development of an Influenza Rapid Diagnostic Kit Specific for the H7 SubtypeKiyoko Iwatsuki-Horimoto, Jianzhong Shi, Xiurong Wang, et al.Msphere|January 10, 2023
SARS-CoV-2 Transmission from Virus-Infected Dead HamstersKiyoko Iwatsuki-Horimoto, Hiroshi Ueki, Mutsumi Ito, et al.Pageof 9